Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: the Australian Trial in Acute Hepatitis C

BACKGROUND: A barrier to hepatitis C virus (HCV) treatment among people who inject drugs (PWID) has been a concern that interferon-based HCV treatment may increase injecting risk behaviours. This study evaluated recent (past month) injecting risk behaviours during follow-up among PWID that did and d...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Drug Policy
Hlavní autoři: Alavi, Maryam, Spelman, Tim, Matthews, Gail V., Haber, Paul S., Day, Carolyn, van Beek, Ingrid, Walsh, Nick, Yeung, Barbara, Bruneau, Julie, Petoumenos, Kathy, Dolan, Kate, Kaldor, John M., Dore, Gregory J, Hellard, Margaret, Grebely, Jason
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4577441/
https://ncbi.nlm.nih.gov/pubmed/26115881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugpo.2015.05.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky